InvestorsHub Logo
Followers 16
Posts 1523
Boards Moderated 0
Alias Born 08/09/2011

Re: Jesspro post# 12791

Tuesday, 05/25/2021 1:53:13 PM

Tuesday, May 25, 2021 1:53:13 PM

Post# of 17446
Boehringer Ingelheim, Lilly (twice), La Jolla, and others have not been able to create a viable LN product. The world is starting to find out that the Glaxo product is an also-ran, at best. I say let the bidding war begin! Maybe it began today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News